Intron a and Magnesium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Intron a (interferon alfa-2b) and Magnesium (magnesium). Common drug interactions include fatigue among females and eyelid oedema among males.

The phase IV clinical study analyzes what interactions people have when they take Intron a and Magnesium. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Intron a?

Intron a has active ingredients of interferon alfa-2b. eHealthMe is studying from 9,320 Intron a users. Check the latest studies of Intron a.

What is Magnesium?

Magnesium has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 121,144 Magnesium users. Check the latest studies of Magnesium.

On Jul, 10, 2026

11 people who take Intron a and Magnesium together, and have interactions are studied.

Intron a and Magnesium drug interactions.

What are the common drug interactions of Intron A and Magnesium, by gender? *:

female:

Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Platelet count decreased
Viral upper respiratory tract infection
White blood cell count increased
Alopecia (absence of hair from areas of the body)
Diarrhoea
Eye haemorrhage (bleeding in the eye)
Fungal infection
Memory impairment

male:

Eyelid oedema (eyelids are swollen and contain excessive fluid)
Haematemesis (vomiting of blood)
Neoplasm progression (growth of tumour)
Neoplasm malignant (cancer tumour)
Rash generalised (rash on most of body parts)
Skin exfoliation (removal of the oldest dead skin cells)
Influenza like illness
Malaise (a feeling of general discomfort or uneasiness)
Death
Fatigue (feeling of tiredness)

What are the common drug interactions of Intron A and Magnesium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Death

50-59:

Haematemesis (vomiting of blood)
Neoplasm malignant (cancer tumour)
Rash generalised (rash on most of body parts)
Skin exfoliation (removal of the oldest dead skin cells)
Fatigue (feeling of tiredness)
Headache (pain in head)
Neoplasm progression (growth of tumour)
Eyelid oedema (eyelids are swollen and contain excessive fluid)

60+:

Nausea (feeling of having an urge to vomit)
Platelet count decreased
Viral upper respiratory tract infection
White blood cell count increased
Influenza like illness
Malaise (a feeling of general discomfort or uneasiness)
Alopecia (absence of hair from areas of the body)
Eye haemorrhage (bleeding in the eye)
Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 18.18%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 18.18%
T-Cell Lymphoma (a blood cell cancer): 1 person, 9.09%
Skin Cancer: 1 person, 9.09%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 1 person, 9.09%
Oncologic Complication: 1 person, 9.09%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 9.09%
Headache (pain in head): 1 person, 9.09%
Blood Disorder: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Intron a and Magnesium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously